Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Audited Financial Results for the quarter/year ended 31st March, 2026 along with Statement of Assets and Liabilities and Cash Flow Statement for the year ended 31st March, 2026.